Article Details

Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value

Retrieved on: 2022-10-18 13:42:20

Tags for this article:

Click the tags to see associated articles and topics

Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value. View article details on hiswai:

Excerpt

Warrants to Purchase Approximately 21 Million Scopus Shares Eliminated Scopus BioPharma's Pure Play Immuno-Oncology Subsidiary, ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up